SeptRx, Inc. Completes Enrollment for its "InterSEPT" CE Mark Trial, Partners With CoRRect Medical GmbH for European Distribution of Its SeptRx(R) Intrapocket PFO Occluder (IPO)
4/23/2012 8:51:15 AM
More...
|
SeptRx, Inc. Reports First 20 Patients Have Been Enrolled in its "InterSEPT" CE Mark Trial of the SeptRx® Intrapocket PFO Occluder (IPO)
1/3/2012 9:31:31 AM
More...
|
SeptRx, Inc. Begins CE Mark Trial of the SeptRx(R) Intrapocket PFO Occluder (IPO)
6/16/2011 11:00:07 AM
More...
|
SeptRx, Inc. Receives 'Series A' to Fund CE Mark Trial of the Septrx(R) Intrapocket PFO Occluder (IPO)
6/6/2011 12:59:22 PM
More...
|